Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neogen (NEOG) EBT Margin (2016 - 2025)

Historic EBT Margin for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to 9.06%.

  • Neogen's EBT Margin rose 1970100.0% to 9.06% in Q4 2025 from the same period last year, while for Nov 2025 it was 70.14%, marking a year-over-year decrease of 149500.0%. This contributed to the annual value of 126.65% for FY2025, which is 1251000.0% down from last year.
  • Neogen's EBT Margin amounted to 9.06% in Q4 2025, which was up 1970100.0% from 20.94% recorded in Q3 2025.
  • Over the past 5 years, Neogen's EBT Margin peaked at 20.94% during Q3 2025, and registered a low of 279.96% during Q2 2025.
  • For the 5-year period, Neogen's EBT Margin averaged around 21.23%, with its median value being 0.15% (2023).
  • Examining YoY changes over the last 5 years, Neogen's EBT Margin showed a top increase of 1970100bps in 2025 and a maximum decrease of -2772600bps in 2025.
  • Quarter analysis of 5 years shows Neogen's EBT Margin stood at 9.91% in 2021, then tumbled by -250bps to 14.82% in 2022, then soared by 89bps to 1.63% in 2023, then plummeted by -12529bps to 206.08% in 2024, then surged by 96bps to 9.06% in 2025.
  • Its EBT Margin stands at 9.06% for Q4 2025, versus 20.94% for Q3 2025 and 279.96% for Q2 2025.